Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022109062 - COMPOSITION FOR NAP PROMOTION

Publication Number WO/2022/109062
Publication Date 27.05.2022
International Application No. PCT/US2021/059778
International Filing Date 17.11.2021
IPC
A61P 25/20 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
20Hypnotics; Sedatives
A61K 45/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 25/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
CPC
A61K 9/2018
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2013Organic compounds, e.g. phospholipids, fats
2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2054
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2022Organic macromolecular compounds
205Polysaccharides, e.g. alginate, gums; Cyclodextrin
2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 9/2059
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2022Organic macromolecular compounds
205Polysaccharides, e.g. alginate, gums; Cyclodextrin
2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
A61K 9/209
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2072characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
209containing drug in at least two layers or in the core and in at least one outer layer
A61K 9/4858
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
4841Filling excipients; Inactive ingredients
4858Organic compounds
A61K 9/4891
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
4891Coated capsules; Multilayered drug free capsule shells
Applicants
  • NAPJITSU, INC. [US]/[US]
Inventors
  • FERRARI, John
Agents
  • CHAMBERS, Scott A.M.
  • ZAPADKA, Matthew D.
Priority Data
63/115,37318.11.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) COMPOSITION FOR NAP PROMOTION
(FR) COMPOSITION POUR FAVORISER LA SIESTE
Abstract
(EN) Provided herein are oral formulations to help create a better power nap. One preferred embodiment of the present invention is a composition that will generally lead to a restorative nap of 30 minutes. Another preferred embodiment is directed to generating a restorative nap in about 10 minutes. One preferred embodiment uses multiple pills with some pills containing a stimulant. By varying the release profile and the substance, it is possible to tailor the nap to the person and to the environment or duration of the nap. We have found that with an embodiment we designate as nootropic Nap 30, seven subjective metrics including tiredness, energy, focus, alertness, feeling good, memory and mood improved over a five-hour period. Compared with coffee or placebo, this Nap 30 composition was more consistent in its effects over time and more stable.
(FR) La présente invention concerne des formulations par voie orale pour aider à créer une meilleure sieste éclair. Un mode de réalisation préféré de la présente invention est une composition qui conduira de manière générale à une sieste régénérante de 30 minutes. Un autre mode de réalisation préféré concerne la génération d’une sieste fortifiante d’environ 10 minutes. Un mode de réalisation préféré utilise de multiples pilules, certaines pilules contenant un stimulant. En faisant varier le profil de libération et la substance, il est possible de personnaliser la sieste à la personne et à l’environnement ou la durée de la sieste. Nous avons découvert qu’avec un mode de réalisation que nous désignons comme produit "Nap 30" nootropique, sept mesures subjectives comprenant la fatigue, l’énergie, la concentration, la vigilance, le bien-être, la mémoire et l’humeur se sont améliorées sur une période de cinq heures. Comparée au café ou un placebo, cette composition de produit Nap 30 était plus uniforme dans ses effets dans le temps et plus stable.
Latest bibliographic data on file with the International Bureau